Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2019

Condensed Financial Information Disclosure [Abstract]

Condensed Consolidating Statement of Operations




	For the Year Ended December 31, 2019
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	20.7		$	2,425.5		$	1,221.7		$	1,074.1		$	(137.0	)	$	4,605.0
Operating expenses:
Salaries and benefits	59.6			1,176.5			608.7			748.9			(20.7		)	2,573.0
Other operating expenses	45.0			351.8			189.3			88.4			(50.9		)	623.6
Occupancy costs	2.1			100.8			27.5			17.3			(65.4		)	82.3
Supplies	—			98.0			49.3			20.6			—			167.9
General and administrative expenses	160.0			—			—			87.0			—			247.0
Depreciation and amortization	19.9			106.8			54.9			37.1			—			218.7
Total operating expenses	286.6			1,833.9			929.7			999.3			(137.0		)	3,912.5
Loss on early extinguishment of debt	7.7			—			—			—			—			7.7
Interest expense and amortization of debt discounts and fees	131.0			24.7			5.6			28.4			(30.0		)	159.7
Other income	(32.3		)	(21.1		)	(7.1		)	—			30.0			(30.5		)
Equity in net income of nonconsolidated affiliates	—			(5.1		)	(0.4		)	(1.2		)	—			(6.7		)
Equity in net income of consolidated affiliates	(492.6		)	(67.0		)	—			—			559.6			—
Management fees	(160.8		)	117.8			43.0			—			—			—
Income from continuing operations before income tax (benefit) expense	281.1			542.3			250.9			47.6			(559.6		)	562.3
Provision for income tax (benefit) expense	(78.2		)	140.3			40.3			13.5			—			115.9
Income from continuing operations	359.3			402.0			210.6			34.1			(559.6		)	446.4
Loss from discontinued operations, net of tax	(0.6		)	—			—			—			—			(0.6		)
Net income	358.7			402.0			210.6			34.1			(559.6		)	445.8
Less: Net income attributable to noncontrolling interests	—			—			(83.3		)	(3.8		)	—			(87.1		)
Net income attributable to Encompass Health	$	358.7		$	402.0		$	127.3		$	30.3		$	(559.6	)	$	358.7
Comprehensive income	$	358.7		$	402.0		$	210.6		$	34.1		$	(559.6	)	$	445.8
Comprehensive income attributable to Encompass Health	$	358.7		$	402.0		$	127.3		$	30.3		$	(559.6	)	$	358.7




	For the Year Ended December 31, 2018
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	21.0		$	2,351.8		$	1,118.9		$	915.9		$	(130.3	)	$	4,277.3
Operating expenses:
Salaries and benefits	49.5			1,132.2			550.4			643.3			(21.4		)	2,354.0
Other operating expenses	37.9			344.3			177.4			75.3			(49.8		)	585.1
Occupancy costs	1.9			95.7			25.4			14.1			(59.1		)	78.0
Supplies	—			95.8			44.9			18.0			—			158.7
General and administrative expenses	161.0			—			—			59.2			—			220.2
Depreciation and amortization	14.3			108.2			47.6			29.6			—			199.7
Government, class action, and related settlements	52.0			—			—			—			—			52.0
Total operating expenses	316.6			1,776.2			845.7			839.5			(130.3		)	3,647.7
Interest expense and amortization of debt discounts and fees	124.2			22.6			2.2			23.5			(25.2		)	147.3
Other income	(22.4		)	(1.0		)	(3.5		)	(0.5		)	25.2			(2.2		)
Equity in net income of nonconsolidated affiliates	—			(7.1		)	(0.4		)	(1.2		)	—			(8.7		)
Equity in net income of consolidated affiliates	(465.6		)	(63.4		)	—			—			529.0			—
Management fees	(153.1		)	114.0			39.1			—			—			—
Income from continuing operations before income tax (benefit) expense	221.3			510.5			235.8			54.6			(529.0		)	493.2
Provision for income tax (benefit) expense	(69.9		)	136.6			38.4			13.8			—			118.9
Income from continuing operations	291.2			373.9			197.4			40.8			(529.0		)	374.3
Income from discontinued operations, net of tax	1.1			—			—			—			—			1.1
Net income	292.3			373.9			197.4			40.8			(529.0		)	375.4
Less: Net income attributable to noncontrolling interests	—			—			(77.8		)	(5.3		)	—			(83.1		)
Net income attributable to Encompass Health	$	292.3		$	373.9		$	119.6		$	35.5		$	(529.0	)	$	292.3
Comprehensive income	$	292.3		$	373.9		$	197.4		$	40.8		$	(529.0	)	$	375.4
Comprehensive income attributable to Encompass Health	$	292.3		$	373.9		$	119.6		$	35.5		$	(529.0	)	$	292.3




	For the Year Ended December 31, 2017
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net operating revenues	$	21.3		$	2,252.5		$	1,006.4		$	759.8		$	(126.1	)	$	3,913.9
Operating expenses:
Salaries and benefits	34.7			1,088.7			508.9			543.3			(21.0		)	2,154.6
Other operating expenses	32.8			324.8			160.2			62.4			(48.6		)	531.6
Occupancy costs	1.9			93.7			23.0			11.4			(56.5		)	73.5
Supplies	—			94.2			41.7			13.4			—			149.3
General and administrative	143.7			—			—			28.0			—			171.7
Depreciation and amortization	8.8			106.6			44.7			23.7			—			183.8
Total operating expenses	221.9			1,708.0			778.5			682.2			(126.1		)	3,264.5
Loss on early extinguishment of debt	10.7			—			—			—			—			10.7
Interest expense and amortization of debt discounts and fees	130.5			23.2			2.5			19.2			(21.0		)	154.4
Other (income) loss	(21.7		)	0.2			(3.6		)	—			21.0			(4.1		)
Equity in net income of nonconsolidated affiliates	—			(6.9		)	(0.4		)	(0.7		)	—			(8.0		)
Equity in net income of consolidated affiliates	(342.1		)	(39.0		)	—			—			381.1			—
Management fees	(145.0		)	109.5			35.5			—			—			—
Income from continuing operations before income tax (benefit) expense	167.0			457.5			193.9			59.1			(381.1		)	496.4
Provision for income tax (benefit) expense	(104.5		)	182.6			66.8			0.9			—			145.8
Income from continuing operations	271.5			274.9			127.1			58.2			(381.1		)	350.6
Loss from discontinued operations, net of tax	(0.4		)	—			—			—			—			(0.4		)
Net income	271.1			274.9			127.1			58.2			(381.1		)	350.2
Less: Net income attributable to noncontrolling interests	—			—			(68.7		)	(10.4		)	—			(79.1		)
Net income attributable to Encompass Health	$	271.1		$	274.9		$	58.4		$	47.8		$	(381.1	)	$	271.1
Comprehensive income	$	271.0		$	274.9		$	127.1		$	58.2		$	(381.1	)	$	350.1
Comprehensive income attributable to Encompass Health	$	271.0		$	274.9		$	58.4		$	47.8		$	(381.1	)	$	271.0

Condensed Consolidating Balance Sheet




	As of December 31, 2019
	Encompass Health Corporation		Guarantor Subsidiaries		Non-guarantor Subsidiaries		Holdings		Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	53.7	$	5.2	$	6.0	$	29.9	$	—		$	94.8
Restricted cash	—		—		57.4		—		—			57.4
Accounts receivable	—		280.4		125.6		100.1		—			506.1
Prepaid expenses and other current assets	64.3		35.4		9.3		7.8		(19.3		)	97.5
Total current assets	118.0		321.0		198.3		137.8		(19.3		)	755.8
Property and equipment, net	133.4		1,246.0		551.2		28.7		—			1,959.3
Operating lease right-of-use assets	10.1		171.5		86.5		43.7		(35.3		)	276.5
Goodwill	—		912.2		323.0		1,070.0		—			2,305.2
Intangible assets, net	17.7		101.7		65.3		291.6		—			476.3
Deferred income tax assets	27.2		11.1		0.1		—		(35.5		)	2.9
Other long-term assets	53.6		85.4		151.6		14.1		—			304.7
Intercompany notes receivable	737.8		—		—		—		(737.8		)	—
Intercompany receivable and investments in consolidated affiliates	3,155.4		523.6		—		—		(3,679.0		)	—
Total assets	$	4,253.2	$	3,372.5	$	1,376.0	$	1,585.9	$	(4,506.9	)	$	6,080.7
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	17.0	$	10.4	$	3.8	$	8.1	$	—		$	39.3
Current operating lease liabilities	1.3		21.9		16.0		12.1		(10.9		)	40.4
Accounts payable	9.8		56.5		24.3		4.0		—			94.6
Accrued payroll	34.8		76.2		40.4		59.1		—			210.5
Accrued interest payable	30.4		2.0		—		—		—			32.4
Other current liabilities	82.2		30.5		68.8		141.6		(19.3		)	303.8
Total current liabilities	175.5		197.5		153.3		224.9		(30.2		)	721.0
Long-term debt, net of current portion	2,670.6		305.4		41.6		5.7		—			3,023.3
Long-term operating lease liabilities	9.0		153.9		73.6		31.9		(24.6		)	243.8
Intercompany notes payable	—		—		—		737.8		(737.8		)	—
Self-insured risks	19.3		—		97.9		—		—			117.2
Other long-term liabilities	26.6		12.2		2.4		37.0		(35.5		)	42.7
Intercompany payable	—		—		66.0		4.4		(70.4		)	—
	2,901.0		669.0		434.8		1,041.7		(898.5		)	4,148.0
Commitments and contingencies
Redeemable noncontrolling interests	—		—		31.4		208.2		—			239.6
Shareholders’ equity:
Encompass Health shareholders’ equity	1,352.2		2,703.5		568.9		336.0		(3,608.4		)	1,352.2
Noncontrolling interests	—		—		340.9		—		—			340.9
Total shareholders’ equity	1,352.2		2,703.5		909.8		336.0		(3,608.4		)	1,693.1
Total liabilities and shareholders’ equity	$	4,253.2	$	3,372.5	$	1,376.0	$	1,585.9	$	(4,506.9	)	$	6,080.7




	As of December 31, 2018
	Encompass Health Corporation		Guarantor Subsidiaries		Non-guarantor Subsidiaries		Holdings		Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Assets
Current assets:
Cash and cash equivalents	$	41.5	$	3.0	$	5.1	$	19.6	$	—		$	69.2
Restricted cash	—		—		59.0		—		—			59.0
Accounts receivable	—		270.7		121.6		75.4		—			467.7
Prepaid expenses and other current assets	36.3		17.6		26.2		4.9		(18.8		)	66.2
Total current assets	77.8		291.3		211.9		99.9		(18.8		)	662.1
Property and equipment, net	123.9		1,041.5		445.2		24.2		—			1,634.8
Goodwill	—		912.2		293.3		895.3		—			2,100.8
Intangible assets, net	21.4		96.6		67.5		257.9		—			443.4
Deferred income tax assets	47.9		28.9		0.1		—		(34.0		)	42.9
Other long-term assets	47.9		100.4		130.9		11.8		—			291.0
Intercompany notes receivable	535.3		—		—		—		(535.3		)	—
Intercompany receivable and investments in consolidated affiliates	2,904.4		457.6		—		—		(3,362.0		)	—
Total assets	$	3,758.6	$	2,928.5	$	1,148.9	$	1,289.1	$	(3,950.1	)	$	5,175.0
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt	$	35.0	$	7.5	$	4.4	$	6.4	$	(17.5	)	$	35.8
Accounts payable	8.9		46.4		30.4		4.3		—			90.0
Accrued payroll	35.0		69.1		35.4		48.9		—			188.4
Accrued interest payable	22.3		2.4		—		—		(0.3		)	24.4
Other current liabilities	154.5		5.1		85.7		89.6		(1.0		)	333.9
Total current liabilities	255.7		130.5		155.9		149.2		(18.8		)	672.5
Long-term debt, net of current portion	2,188.7		262.1		20.0		7.8		—			2,478.6
Intercompany notes payable	—		—		—		535.3		(535.3		)	—
Self-insured risks	16.1		—		103.5		—		—			119.6
Other long-term liabilities	21.4		17.1		5.0		76.0		(33.9		)	85.6
Intercompany payable	—		—		48.9		4.2		(53.1		)	—
	2,481.9		409.7		333.3		772.5		(641.1		)	3,356.3
Commitments and contingencies
Redeemable noncontrolling interests	—		—		38.3		223.4		—			261.7
Shareholders’ equity
Encompass Health shareholders’ equity	1,276.7		2,518.8		497.0		293.2		(3,309.0		)	1,276.7
Noncontrolling interests	—		—		280.3		—		—			280.3
Total shareholders’ equity	1,276.7		2,518.8		777.3		293.2		(3,309.0		)	1,557.0
Total liabilities and shareholders’ equity	$	3,758.6	$	2,928.5	$	1,148.9	$	1,289.1	$	(3,950.1	)	$	5,175.0

Condensed Consolidating Statement of Cash Flows



	For the Year Ended December 31, 2019
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash (used in) provided by operating activities	$	(110.8	)	$	450.3		$	247.9		$	47.9		$	—		$	635.3
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(217.8		)	—			—			(13.7		)	—			(231.5		)
Purchases of property and equipment	(38.6		)	(207.3		)	(117.9		)	(8.6		)	—			(372.4		)
Additions to capitalized software costs	(7.4		)	(0.7		)	(1.4		)	(3.5		)	—			(13.0		)
Purchases of intangible assets	—			(18.0		)	—			(0.7		)	—			(18.7		)
Proceeds from sale of restricted investments	—			—			17.6			—			—			17.6
Purchases of restricted investments	—			—			(30.9		)	(2.0		)	—			(32.9		)
Funding of intercompany note receivable	(64.0		)	—			—			—			64.0			—
Proceeds from repayment of intercompany note receivable	93.0			—			17.5			—			(110.5		)	—
Other, net	(8.3		)	8.2			(6.7		)	0.3			—			(6.5		)
Net cash provided used in investing activities	(243.1		)	(217.8		)	(121.8		)	(28.2		)	(46.5		)	(657.4		)
Cash flows from financing activities:
Proceeds from bond issuance	1,000.0			—			—			—			—			1,000.0
Principal payments on debt, including pre-payments	(517.8		)	—			(1.7		)	—			—			(519.5		)
Principal borrowings on intercompany note payable	—			—			—			64.0			(64.0		)	—
Principal payments on intercompany note payable	(17.5		)	—			—			(93.0		)	110.5			—
Borrowings on revolving credit facility	635.0			—			—			—			—			635.0
Payments on revolving credit facility	(620.0		)	—			—			—			—			(620.0		)
Principal payments under finance lease obligations	(0.7		)	(8.3		)	(2.6		)	(7.9		)	—			(19.5		)
Debt amendment and issuance costs	(21.5		)	—			—			—			—			(21.5		)
Repurchases of common stock, including fees and expenses	(45.9		)	—			—			—			—			(45.9		)
Dividends paid on common stock	(108.6		)	—			—			(0.1		)	—			(108.7		)
Purchase of equity interests in consolidated affiliates	(162.9		)	—			—			—			—			(162.9		)
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(79.8		)	—			—			(79.8		)
Taxes paid on behalf of employees for shares withheld	(15.4		)	—			—			(1.2		)	—			(16.6		)
Contributions from consolidated affiliates	—			—			15.9			—			—			15.9
Other, net	(4.4		)	—			—			(3.9		)	—			(8.3		)
Change in intercompany advances	245.8			(222.0		)	(56.5		)	32.7			—			—
Net cash provided by (used in) financing activities	366.1			(230.3		)	(124.7		)	(9.4		)	46.5			48.2
Increase in cash, cash equivalents, and restricted cash	12.2			2.2			1.4			10.3			—			26.1
Cash, cash equivalents, and restricted cash at beginning of year	41.5			3.0			69.4			19.6			—			133.5
Cash, cash equivalents and restricted cash at end of year	$	53.7		$	5.2		$	70.8		$	29.9		$	—		$	159.6

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	41.5		$	3.0		$	5.1		$	19.6		$	—		$	69.2
Restricted cash at beginning of period	—			—			59.0			—			—			59.0
Restricted cash included in other long-term assets at beginning of period	—			—			5.3			—			—			5.3
Cash, cash equivalents, and restricted cash at beginning of period	$	41.5		$	3.0		$	69.4		$	19.6		$	—		$	133.5

Cash and cash equivalents at end of period	$	53.7		$	5.2		$	6.0		$	29.9		$	—		$	94.8
Restricted cash at end of period	—			—			57.4			—			—			57.4
Restricted cash included in other long-term assets at end of period	—			—			7.4			—			—			7.4
Cash, cash equivalents, and restricted cash at end of period	$	53.7		$	5.2		$	70.8		$	29.9		$	—		$	159.6

Supplemental schedule of noncash financing activity:
Intercompany note activity	$	(232.9	)	$	—		$	—		$	232.9		$	—		$	—



	For the Year Ended December 31, 2018
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash (used in) provided by operating activities	$	(11.3	)	$	422.2		$	259.0		$	92.5		$	—		$	762.4
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(131.4		)	—			—			(12.5		)	—			(143.9		)
Purchases of property and equipment	(34.1		)	(133.9		)	(79.9		)	(6.6		)	—			(254.5		)
Additions to capitalized software costs	(14.1		)	(0.1		)	—			(1.8		)	—			(16.0		)
Purchases of intangible assets	(2.5		)	—			(0.1		)	(3.1		)	—			(5.7		)
Proceeds from sale of restricted investments	—			—			11.6			—			—			11.6
Purchases of restricted investments	—			—			(13.3		)	—			—			(13.3		)
Proceeds from repayment of intercompany note receivable	87.0			—			—			—			(87.0		)	—
Other, net	(6.0		)	2.8			—			0.5			—			(2.7		)
Net cash used in investing activities	(101.1		)	(131.2		)	(81.7		)	(23.5		)	(87.0		)	(424.5		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(17.6		)	—			(3.0		)	—			—			(20.6		)
Principal payments on intercompany notes payable	—			—			—			(87.0		)	87.0			—
Borrowings on revolving credit facility	325.0			—			—			—			—			325.0
Payments on revolving credit facility	(390.0		)	—			—			—			—			(390.0		)
Principal payments under finance lease obligations	—			(8.4		)	(4.2		)	(5.3		)	—			(17.9		)
Debt amendment and issuance costs	—			—			(0.1		)	—			—			(0.1		)
Dividends paid on common stock	(100.7		)	—			—			(0.1		)	—			(100.8		)
Purchase of equity interests in consolidated affiliates	(65.1		)	—			—			—			—			(65.1		)
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(75.4		)	—			—			(75.4		)
Taxes paid on behalf of employees for shares withheld	(7.4		)	—			—			(0.9		)	—			(8.3		)
Contributions from consolidated affiliates	—			—			12.6			—			—			12.6
Other, net	3.0			—			13.2			3.2			—			19.4
Change in intercompany advances	372.4			(282.5		)	(118.9		)	29.0			—			—
Net cash provided by (used in) financing activities	119.6			(290.9		)	(175.8		)	(61.1		)	87.0			(321.2		)
Increase in cash, cash equivalents, and restricted cash	7.2			0.1			1.5			7.9			—			16.7
Cash, cash equivalents, and restricted cash at beginning of year	34.3			2.9			67.9			11.7			—			116.8
Cash, cash equivalents, and restricted cash at end of year	$	41.5		$	3.0		$	69.4		$	19.6		$	—		$	133.5

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	34.3		$	2.9		$	5.5		$	11.7		$	—		$	54.4
Restricted cash at beginning of period	—			—			62.4			—			—			62.4
Cash, cash equivalents, and restricted cash at beginning of period	$	34.3		$	2.9		$	67.9		$	11.7		$	—		$	116.8

Cash and cash equivalents at end of period	$	41.5		$	3.0		$	5.1		$	19.6		$	—		$	69.2
Restricted cash at end of period	—			—			59.0			—			—			59.0
Restricted cash included in other long-term assets at end of period	—			—			5.3			—			—			5.3
Cash, cash equivalents, and restricted cash at end of period	$	41.5		$	3.0		$	69.4		$	19.6		$	—		$	133.5

Supplemental schedule of noncash investing activities:
Intercompany note activity	$	(136.8	)	$	—		$	—		$	136.8		$	—		$	—



	For the Year Ended December 31, 2017
	Encompass Health Corporation			Guarantor Subsidiaries			Non-guarantor Subsidiaries			Holdings			Eliminating Entries			Encompass Health Consolidated
	(In Millions)
Net cash provided by operating activities	$	28.2		$	385.9		$	181.2		$	63.0		$	—		$	658.3
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired	(10.9		)	—			—			(27.9		)	—			(38.8		)
Purchases of property and equipment	(39.4		)	(106.5		)	(75.4		)	(4.5		)	—			(225.8		)
Additions to capitalized software costs	(16.3		)	(0.3		)	(0.1		)	(2.5		)	—			(19.2		)
Purchases of intangible assets	—			—			—			(3.7		)	—			(3.7		)
Proceeds from sale of restricted investments	—			—			4.2			—			—			4.2
Purchases of restricted investments	—			—			(8.5		)	—			—			(8.5		)
Proceeds from repayment of intercompany note receivable	51.0			—			—			—			(51.0		)	—
Other, net	(3.7		)	11.7			0.2			0.6			—			8.8
Net cash used in investing activities	(19.3		)	(95.1		)	(79.6		)	(38.0		)	(51.0		)	(283.0		)
Cash flows from financing activities:
Principal payments on debt, including pre-payments	(126.9		)	—			(3.0		)	—			—			(129.9		)
Principal payments on intercompany notes payable	—			—			—			(51.0		)	51.0			—
Borrowings on revolving credit facility	273.3			—			—			—			—			273.3
Payments on revolving credit facility	(330.3		)	—			—			—			—			(330.3		)
Principal payments under finance lease obligations	—			(7.3		)	(3.9		)	(4.1		)	—			(15.3		)
Debt amendment and issuance costs	(4.1		)	—			—			—			—			(4.1		)
Repurchases of common stock, including fees and expenses	(38.1		)	—			—			—			—			(38.1		)
Dividends paid on common stock	(91.5		)	—			—			—			—			(91.5		)
Proceeds from exercising stock warrants	26.6			—			—			—			—			26.6
Distributions paid to noncontrolling interests of consolidated affiliates	—			—			(51.9		)	—			—			(51.9		)
Taxes paid on behalf of employees for shares withheld	(19.5		)	—			—			(0.3		)	—			(19.8		)
Contributions from consolidated affiliates	—			—			20.8			—			—			20.8
Other, net	1.0			—			—			(0.7		)	—			0.3
Change in intercompany advances	314.3			(282.2		)	(62.0		)	29.9			—			—
Net cash provided by (used in) financing activities	4.8			(289.5		)	(100.0		)	(26.2		)	51.0			(359.9		)
Increase in cash, cash equivalents, and restricted cash	13.7			1.3			1.6			(1.2		)	—			15.4
Cash, cash equivalents, and restricted cash at beginning of year	20.6			1.6			66.3			12.9			—			101.4
Cash, cash equivalents, and restricted cash at end of year	$	34.3		$	2.9		$	67.9		$	11.7		$	—		$	116.8

Reconciliation of Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents at beginning of period	$	20.6		$	1.6		$	5.4		$	12.9		$	—		$	40.5
Restricted cash at beginning of period	—			—			60.9			—			—			60.9
Cash, cash equivalents, and restricted cash at beginning of period	$	20.6		$	1.6		$	66.3		$	12.9		$	—		$	101.4

Cash and cash equivalents at end of period	$	34.3		$	2.9		$	5.5		$	11.7		$	—		$	54.4
Restricted cash at end of period	—			—			62.4			—			—			62.4
Cash, cash equivalents, and restricted cash at end of period	$	34.3		$	2.9		$	67.9		$	11.7		$	—		$	116.8

Supplemental schedule of noncash financing activities:
Intercompany note activity	$	(8.8	)	$	—		$	—		$	8.8		$	—		$	—
Conversion of convertible debt	319.4			—			—			—			—			319.4